Swiss Severe Asthma Registry (SSAR)- Good asthma control and high number of exacerbations. How does this fit?

Jaun, Fabienne; Capponi, Janina; Jochmann, Anja; Pavlov, Nikolay; Kern, Lukas; Widmer, Sandra; Clarenbach, Christian F.; Sievi, Noriane A.; Steurer-Stey, Claudia; Duchna, Hans‐Werner; Rothe, Thomás; Dinic, Marinela; Oberhänsli, Carina; Gianella, Pietro; Lovera, Michela Paronitti; Charbonnier, Florian; Salamin, Marlène; Bridevaux, Pierre‐Olivier; Garnier, Christophe von; Leüppi, Jörg D.

doi:10.1183/13993003.congress-2021.pa1099

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…*Sensitivity, specificity, likelihood ratios and accuracy from washout methods calculated as compared with the reference standard MCT 20 (methacholine challenge test according to ≥20% fall of FEV1).†Sensitivity, specificity, likelihood ratios and accuracy from washout methods calculated as compared with the reference standard MCT 40 (positive methacholine challenge test according to fall of ≥40% of specific airway conductance).‡Disease prevalence of 6% 27FEV1, forced expiratory volume in the first second; MCT, methacholine challenge test; N 2 MBW, nitrogen multiple breath washout; N 2 SBW, nitrogen single breath washout; SGeff, specific airway conductance; SIII, slope III from N 2 SBW.…”

Section: Resultsmentioning

confidence: 99%

Single and multiple breath nitrogen washout compared with the methacholine test in patients with suspected asthma and normal spirometry

Siebeneichler,

Schumann,

Karakioulaki

et al. 2024

BMJ Open Resp Res

View full text Add to dashboard Cite

BackgroundMethods used to assess ventilation heterogeneity through inert gas washout have been standardised and showed high sensitivity in diagnosing many respiratory diseases. We hypothesised that nitrogen single or multiple breath washout tests, respectively nitrogen single breath washout (N2SBW) and nitrogen multiple breath washout (N2MBW), may be pathological in patients with clinical suspicion of asthma but normal spirometry. Our aim was to assess whether N2SBW and N2MBW are associated with methacholine challenge test (MCT) results in this population. We also postulated that an alteration in SIIIat N2SBW could be detected before the 20% fall of forced expiratory volume in the first second (FEV1) in MCT.Study design and methodsThis prospective, observational, single-centre study included patients with suspicion of asthma with normal spirometry. Patients completed questionnaires on symptoms and health-related quality-of-life and underwent the following lung function tests: N2SBW (SIII), N2MBW (Lung clearance index (LCI), Scond, Sacin), MCT (FEV1and sGeff) as well as N2SBW between each methacholine dose.Results182 patients were screened and 106 were included in the study, with mean age of 41.8±14 years. The majority were never-smokers (58%) and women (61%). MCT was abnormal in 48% of participants, N2SBW was pathological in 10.6% at baseline and N2MBW abnormality ranged widely (LCI 81%, Scond18%, Sacin43%). The dose response rate of the MCT showed weak to moderate correlation with the subsequent N2SBW measurements during the provocation phases (ρ 0.34–0.50) but no correlation with N2MBW.ConclusionsBoth MCT and N2washout tests are frequently pathological in patients with suspicion of asthma with normal spirometry. The weak association and lack of concordance across the tests highlight that they reflect different but not interchangeable pathological pathways of the disease.

show abstract